Abstract 2269: ATR inhibitor M6620 enhances anti-tumor efficacy of the combination of the anti-PD-L1 antibody avelumab with platinum-based chemotherapy
暂无分享,去创建一个
P. Soulard | A. Blaukat | A. Zimmermann | M. Alimzhanov | F. Zenke | G. Sim | A. Schroeder | J. Halle | C. Amendt | K. Mehr